Peptide Association LLC is a for-profit company. We receive compensation from the clinical providers listed on this site. We are not an accrediting body, a licensing board, or a government-affiliated organization. See exactly how we make money.
BPC-157 + TB-500
BPC-157 + TB-500 Recovery Stack
Dosing
BPC-157 250 mcg daily + TB-500 2.0 mg 2x/week near injury site.
Cycle Length
6–8 weeks
Contraindications
Active cancer is an absolute contraindication.
Notes
Most popular recovery combination in clinical practice.
BPC-157 + TB-500 is not FDA-approved and does not currently have a lawful prescription or compounding pathway in the United States. This protocol reference is educational only.
This protocol is for educational purposes only. Always consult a qualified healthcare provider before starting any peptide therapy.